Innovation is essential to staying competitive in the fast-paced corporate environment of today. One strategy that has gained significant traction in recent years is Corporate Venture Capital (CVC). This strategic approach involves large corporations investing their funds directly in external startup companies, resulting in a symbiotic relationship that fuels innovation and drives mutual growth.
Table of Contents
Defining Corporate Venture Capital
Corporate Venture Capital, often abbreviated as CVC, is more than just an investment; it’s a strategic partnership between established corporations and innovative startups. This practice goes beyond mere financial backing. CVC entails a large firm taking an equity stake in a small but innovative or specialist firm, often providing not only capital but also management expertise and marketing support. The ultimate goal? To gain a distinct competitive advantage in the market.
Distinguishing Features of CVC
To truly grasp the concept of CVC, it’s crucial to understand what sets it apart from other investment models. Unlike investing through external funds managed by third parties, CVC involves a direct equity stake taken by the investing corporation itself. Furthermore, CVC is not synonymous with traditional venture capital (VC). It represents a specific subset of venture capital that focuses on collaboration between established corporations and external startups.
The Essence of Corporate Venturing
At its core, Corporate Venturing revolves around establishing collaborative partnerships with external entities to drive mutual growth. These external ventures can take the form of early-stage startups or scaleup companies that have already found their product/market fit. The defining feature is that these ventures come from outside the organization, injecting fresh perspectives and innovation into the corporate ecosystem. However, managing a successful CVC unit is no small feat; it involves navigating the challenges that arise from the intersection of corporate rigidity and startup dynamism.
Objectives of CVC
According to Henry Chesbrough, a professor at UC Berkeley’s Haas School of Business, CVC is characterized by two key elements: its objectives and the level of connection between the startup and the investing company. Unlike traditional private VC, CVC aims to achieve both strategic and financial goals. The goal of strategic CVC investments is to increase the parent company’s business’s sales and earnings. This often involves identifying synergies between the established corporation and the startup, leveraging each other’s strengths for mutual benefit.
On the other hand, financially driven CVC investments focus on leveraging returns. By investing strategically, parent firms seek to maximize the independent revenue and profit generated by the startup itself. This can lead to avenues like initial public offerings (IPOs) or selling stakes to third parties. The goal is to achieve financial success that rivals or even surpasses private VC investors. Corporations believe that their deep market and technology knowledge, combined with their financial strength, give them a competitive edge in the world of venture investing.
Balancing Act: Strategic and Financial Goals
Striking a balance between strategic and financial objectives is the cornerstone of a successful CVC. In the long run, strategic investments contribute to financial value. However, short-term financial goals should not overshadow long-term strategic objectives. Overemphasizing short-term gains could undermine the potential for sustained growth and innovation. Therefore, parent firms meticulously screen venture proposals for their strategic alignment before subjecting them to financial scrutiny.
Recent empirical studies have shed light on the approach European and American incumbent firms take toward CVC. Results reveal that European parent firms often invest with both strategic and financial considerations in mind. In contrast, American parent firms tend to lean more toward strategic investments, showcasing differences in investment styles. Regardless of the region, a strategic motive remains a common thread among successful CVC endeavors.
Linking Ventures for Operational Excellence
The second hallmark of corporate VC investments lies in the level of integration between the startup and the investing company’s operations. A startup with strong ties to the investing corporation can tap into its manufacturing facilities, distribution channels, technology, and brand power. This synergy can enable the startup to leverage the established company’s business practices to enhance its own product development, sales, and service.
However, this linkage can also pose challenges. External ventures may introduce new capabilities that disrupt existing corporate processes. To manage this, some corporations house these capabilities in separate legal entities to protect them from internal resistance. If the startup’s processes prove successful, the investing corporation may consider adopting similar practices. In some cases, the corporation might even explore acquiring the startup.
Exploring Corporate Venture Capital: Strategies and Stages
Venturing into the world of innovation and investment, Corporate Venture Capital (CVC) plays a pivotal role in shaping the business landscape. This article delves into the intricate strategies and financing stages of CVC, shedding light on its diverse motivations and avenues for growth.
Driving Investments: Advancing Business Strategies
Driving investments entail a tightly linked strategic alignment between the investing company’s operations and the startup being funded. The goal is to integrate key growth areas within startups with the company’s initiatives. This synergistic approach seeks to enhance the current business strategy, capitalizing on growth potential while mitigating risks.
Enabling Investments: Embracing Complementary Products
Enabling investments, though not closely tied to the investing company’s operations, focus on complementary products. The idea is to stimulate industry demand through successful investments, consequently benefiting the investing company’s products. Success hinges on capturing a significant portion of the market growth stimulated.
Emergent Investments: Navigating Uncharted Territories
Emergent investments, while linked to the investing company’s operations, don’t align with its current strategies. These investments serve as options for strategic value, adapting to changes in the business environment. This strategy allows for exploring new markets and gathering vital information that could reshape the company’s direction.
Passive Investments: Pursuing Financial Returns
Passive investments, devoid of strategic alignment, solely offer financial returns. These investments don’t actively contribute to advancing the investing company’s business and are generally less advantageous due to their lack of strategic impact.
Financing Stages: Navigating Growth
The journey of financing startup companies unfolds in distinct stages, each catering to specific developmental needs:
Early-stage Financing: From Concept to Creation
At the early stage, startups are conceptualizing their ideas. Capital supports market research, product development, and team establishment. Early-stage financing paves the way for subsequent phases and the initiation of product launch preparations.
Seed Capital Funds: Shaping Early-stage Companies
Seed capital funds aid early-stage companies in refining their concepts and prototypes. These investments stimulate product development and market research, while legal matters such as patents are addressed. Around 20% of companies typically progress to the next funding round.
Expansion Financing: Fueling Growth
Second-stage financing targets companies already selling products, facilitating their expansion. This phase allocates funds for recruiting employees, enhancing engineering, sales, and marketing functions. It supports companies on the brink of profitability or already breaking even.
Initial Public Offering (IPO): The Pinnacle of Success
Going public through an IPO marks a major achievement for startups. This phase enables investment firms to achieve substantial returns on their investments. The startup’s stock becomes publicly tradable, providing an opportunity for both financial gains and investor exit strategies.
Mergers and Acquisitions: Shaping the Future
In a changing economic landscape, mergers and acquisitions offer an alternative path to success. Venture capital firms consider aligning startups with complementary products or merging with other entities to leverage shared resources. This approach facilitates industry positioning, cost savings, and liquidity.
Empowering Innovation and Growth
CVC’s strategic maneuvers and financing stages shape the landscape of innovation and investment. From driving business strategies to embracing emerging markets, CVC plays a pivotal role in fostering collaboration and growth. As startups evolve through various financing phases, the intricate dance of investment and innovation continues to shape the business world.
Venturing into the dynamic world of healthcare innovation, corporate venture capital (CVC) takes center stage. This article unveils the strategies and trends behind CVC activities within the healthcare industry, shedding light on the structure, investment types, and driving motivations that shape this crucial landscape.
Unveiling the Healthcare CVC Landscape
Structure: A Multifaceted Approach
Healthcare corporate venture capital takes shape through distinct organizational structures, with divisions within larger healthcare companies and wholly owned subsidiaries as the primary players. Both models often engage in strategic partnerships, with the primary company managing the fund while forging partnerships with limited partners. This unique approach fosters collaboration and investment synergies.
Investment Types: Navigating the Biotech and Pharmaceutical Frontier
Within the healthcare domain, biotechnology and pharmaceutical ventures dominate the corporate venture capital landscape. Key players such as Eli Lilly and Company, GlaxoSmithKline, Takeda Pharmaceutical Company (TCP), Biogen Idec, and Roche drive advancements in scientific and technological discoveries. These venture arms prioritize ventures that align with their parent companies’ focus, investing in companies with similar products or proposed solutions. The portfolio of Takeda Research Investment, for instance, spans diverse areas, from modulating ion channels to innovative approaches for treating neurological disorders. This approach positions healthcare CVC units as strategic financial investors, nurturing advancements that align with both industry priorities and broader scientific pursuits.
Venturing into the Financing Process: A Strategic Journey
The financing process charts the course taken by CVCs, from initial engagement with potential startups to the culmination of the first round of financing.
- Startup Connection: Startup companies seeking funding initiate contact with CVCs, while CVCs also proactively seek out startups with potential.
- Pitching the Plan: The startup management team presents a comprehensive business plan to the CVC. If the plan generates interest, the CVC requests additional information, including product demonstrations, to further evaluate the startup’s potential.
- Due Diligence: Both sides engage in due diligence. The CVC conducts a thorough investigation into the startup’s product, technology, market, and other relevant aspects. Simultaneously, the startup is evaluated for its financials, projected performance, employees, suppliers, and customer base.
- Valuation and Term Sheet: If the CVC is intrigued by the startup’s offerings, it assesses the startup’s value and communicates it via a term sheet. Negotiations ensue, leading to an agreement on the purchase price and investor equity.
- Finalizing Business Terms: Legal counsels from both sides collaborate to finalize the term sheet, including investment business terms. This stage also establishes a lock-up time period during which the startup refrains from exploring other investment opportunities.
- Negotiations and Finalization: Negotiations continue between the legal counsels of the CVC and the startup, addressing both legal and business matters. Comprehensive transaction documents are reviewed and refined.
- Closing the Deal: The closing of financing marks the final step, with immediate execution of definitive agreements or a brief waiting period. This phase ensures all due diligence is complete and aligns with the startup’s financial needs.
Predicting Trends and Embracing Innovation
As the healthcare landscape evolves, CVC activities are poised for transformation. The convergence of technological advancements and medical breakthroughs promises new avenues for strategic investment. By embracing innovative startups and aligning with broader industry trends, healthcare CVCs position themselves as catalysts for change, shaping the future of healthcare innovation.
Decoding Healthcare Corporate Venture Capital: Unveiling Motivations and Trends
Diving into the realm of healthcare corporate venture capital (CVC) offers a fascinating glimpse into the motivations driving investments and the evolving landscape. This article unveils the core reasons behind healthcare-related companies’ pursuit of CVC, explores prevailing trends, and delves into emerging sectors that are shaping the future of healthcare innovation.
Unlocking Strategic and Financial Motivations
Pursuing New Avenues and Innovations
The strategic motivations fueling healthcare CVC investments are diverse and potent. An essential strategic drive is the quest for novel directions and innovative products. Unlike their parent companies, most CVC units boast broader scopes. They actively explore a wide spectrum of investment prospects, closely aligned with their parent’s operations. The goal is to synergize technologies that either enhance existing product lines or lead the parent company into uncharted industry domains, spurring fresh growth avenues.
Complementing and Elevating Activities
Another strategic impetus propelling healthcare CVC endeavors is the desire to complement and elevate the parent company’s activities. Despite possessing their research and development divisions, these companies recognize the value of external innovations. Often, this synergy emerges when startups share a resemblance in their offerings to those of the parent company. Beyond product enhancement, this extends to refining manufacturing processes, underscoring the multifaceted approach CVC units adopt to bolster the parent company’s success.
Charting Current Trends and Future Prospects
The aftermath of the 2009 economic downturn reverberated through the corporate venture capital arena, and healthcare experienced its ripples. Despite the challenges, the healthcare industry, known for its resilience, beckons investors. As corporations safeguard their cash, the first glimmers of positive momentum in corporate venture capital emerge from healthcare. Initiatives like the recently launched venture fund by Merck Serono and Ascension Health Ventures’ closed fund exemplify the cautious optimism permeating the healthcare venture capital landscape. The latest survey on the most influential healthcare corporate venture capital divisions underscores their growing influence, outshining many independent venture capital entities.
Forging Collaborative Pathways: Technology and Process Exchanges
A trend gathering momentum in the wake of scarce venture capital funds is strategic partnerships forged on technology and process exchanges. In contrast to traditional fund-based collaborations, these partnerships rely on sharing technologies and process information. As liquidity becomes scarcer, this collaborative model proves effective, enabling companies to share developed technologies seamlessly. Emerging partnerships between established giants and agile startups are reminiscent of the “David and Goliath” narrative, set to shape the future of healthcare innovation.
Emerging Sectors and Investment Landscapes
Evolving Investment Patterns
The investment landscape in the healthcare sector has undergone transformative shifts. Initially dominated by investments in software and telecommunications in 1998, the tides shifted by 2006. Biotechnology and medical devices emerged as prime investment sectors for both venture capital firms and CVC. However, health services witnessed a decline during this period. Interestingly, while biotechnology CVC investments outpace those from venture capital firms, medical devices, and health services don’t enjoy the same prominence within CVC investments.
The Unveiling of Emerging Sectors
As the healthcare landscape evolves, certain sectors rise to prominence within the CVC domain. Software, telecommunications, semiconductors, and media/entertainment emerge as dynamic sectors capturing CVC investments. Amid technological breakthroughs and evolving consumer demands, these sectors exemplify the convergence of innovation and strategic investments, shaping the healthcare landscape of tomorrow.
Supporting a Future of Innovation
In the intricate tapestry of healthcare corporate venture capital, strategic motivations and evolving trends intertwine to shape the future. The healthcare sector, renowned for its adaptability, navigates challenges and embraces innovation. As diverse sectors burgeon with potential and collaborative partnerships pave the way, healthcare CVC propels an era of transformation, fueling breakthroughs and advancing the boundaries of innovation.
Exploring Healthcare Corporate Venture Capital: A Look at Sectors and Key Players
Unveiling the Thriving Sectors for Corporate Venture Capital Investments
Venturing into the dynamic realm of corporate venture capital (CVC), certain sectors gleam with promise and innovation. This article unveils the top sectors commanding CVC investments, delving into the sectors that are propelling the future of healthcare advancement.
Pioneering Sectors Capturing CVC Attention
Biotechnology: Leading the Charge
Biotechnology stands at the forefront of CVC investments, a testament to its transformative potential. Companies harness the power of biotechnology to revolutionize medical treatments, ranging from novel therapies to innovative diagnostics. The allure of breakthrough discoveries drives CVC interest, aligning with strategic goals to pioneer advancements in healthcare.
Software: Enabling Healthcare Innovation
Software emerges as a pivotal sector attracting CVC investments. The convergence of healthcare and technology fuels the demand for innovative software solutions. From electronic health records to telemedicine platforms, software catalyzes healthcare transformation, igniting CVC’s interest in cutting-edge ventures that redefine patient care and operational efficiency.
Telecommunications: Bridging Healthcare Divides
Telecommunications occupies a strategic nexus in healthcare, offering avenues to bridge geographical barriers and enhance patient access. CVC investments in this sector signal a commitment to telehealth solutions, aiming to amplify healthcare reach while optimizing care delivery. The marriage of telecommunications and healthcare unveils new vistas of connectivity and patient empowerment.
Semiconductors: Powering Medical Devices
The semiconductor sector commands CVC’s attention due to its pivotal role in powering advanced medical devices. From wearable health monitors to imaging technologies, semiconductors underpin medical innovation. CVC investments in this sector resonate with the drive to foster cutting-edge medical devices that elevate patient outcomes and revolutionize diagnostics.
Media/Entertainment: Shaping Healthcare Engagement
The media and entertainment sector infiltrates healthcare through innovative channels. Health education, patient engagement, and wellness promotion find resonance in this sector. CVC investments signal an embrace of creative solutions that harness media and entertainment to empower patients, disseminate health information, and foster proactive wellness.
Diverse Investment Trends within Life Sciences
The life sciences sector resonates with billion-dollar investments, propelling renowned companies to prominence. Boston Scientific, Amgen, Genentech, and others stand as testaments to the impact of venture capital backing. The life sciences encompass biotechnology and medical devices, with CVC investments fueling advancements in both realms. Biotechnology garners $4.5 billion, while medical devices and equipment secure $2.7 billion, exemplifying the strategic focus of CVC endeavors.
Nurturing Innovations through Strategic Players
Eli Lilly Corporate Business Development
Eli Lilly Corporate Business Development, a CVC division, embodies the commitment of Eli Lilly and Company to foster healthcare innovation. With a strategic focus on growth segments, it mirrors the dynamic intersection of energy, industry, and healthcare sectors. Their investments echo their dedication to driving transformative advancements that redefine healthcare landscapes.
Johnson & Johnson Development Corporation
JJDC, the venture capital subsidiary of Johnson & Johnson, embodies a strategic commitment to nurturing healthcare innovation. This venture capital arm propels the advancement of pioneering medical solutions, encapsulating the ethos of Johnson & Johnson’s mission to revolutionize patient care.
Siemens Venture Capital
Siemens Venture Capital catalyzes growth across energy, industry, and healthcare sectors. Their investments reflect the quest for breakthrough solutions that redefine these domains. With a global presence spanning Germany, the U.S., China, and India, Siemens Venture Capital ignites transformation on a global scale.
Kaiser Permanente Ventures
Kaiser Permanente Ventures epitomizes the integration of medical devices, healthcare services, and information technology. Their strategic investments epitomize the commitment to enhancing patient care, fostering technological innovation, and revolutionizing healthcare delivery.
Shaping a Transformative Future through CVC
In the intricate tapestry of healthcare corporate venture capital, sectors converge with strategic players to usher in a new era of innovation. Biotechnology, software, telecommunications, semiconductors, and media/entertainment emerge as guiding beacons, steering healthcare toward groundbreaking advancements. The fusion of technology, innovation, and strategic investments propels a future where patient care is redefined and healthcare barriers are shattered.
Exploring Corporate Venture Capital Across Sectors
Unveiling the Dynamics of Corporate Venture Capital Investments
Evaluating Opportunities: A Holistic Approach
When it comes to seizing opportunities, meticulous evaluation is key. Corporate venture capital (CVC) initiatives are no exception. Here, we delve into the multifaceted criteria that guide CVC investments, offering insights into the thought process that shapes strategic decisions.
Unraveling the Criteria Driving CVC Investments
In the realm of CVC, every opportunity undergoes rigorous assessment. The following criteria serve as guiding pillars, steering investments toward ventures with the potential to redefine industries:
Industry Focus: Navigating Healthcare Frontiers
Healthcare emerges as a focal point, spanning medical devices, information technology, and services. Yet, the scope extends further, encompassing selective investments in healthcare venture funds. This strategic outlook aligns with the pursuit of innovation that holds the power to reshape healthcare landscapes.
Investment Size: Precision in Funding
Precision marks the investment landscape, with approximately $5 million per round and a potential of up to $10 million per company. This nuanced approach ensures optimal allocation of resources, fostering growth while maintaining financial prudence.
Company Stage: Balancing Growth Trajectories
Strategic timing characterizes CVC investments, targeting expansion- to late-stage companies within a three-to-five-year window. This calculated approach aligns investments with potential liquidating events, optimizing growth trajectories.
Adoption Potential: Driving Sustainable Transformation
Investments are steered toward ventures boasting a sustainable competitive advantage. The allure lies in compelling benefits that resonate with market needs, igniting widespread adoption and shaping industry dynamics.
Management Team: Building on Expertise
An established management team is pivotal, with demonstrated experience, depth, and capability to scale businesses and attract customers. This emphasis on leadership prowess fosters a robust foundation for growth.
Board Observer Seat: Nurturing Engagement
A testament to collaborative engagement, CVC often secures a Board observer seat for each portfolio company. This strategic involvement bolsters alignment, facilitating dynamic contributions to the venture’s evolution.
CVC in Information and Communication Technology
Navigating Technology Cycles
The NASDAQ’s fluctuations over a decade showcased the cyclical nature of technology investments. Despite this, non-technology firms exhibited a consistent interest in investing their CVC resources in information and communication technology. A blend of resilience and strategic foresight underpins these investments.
Global Expansion in Technology Ventures
A global panorama emerged, with non-US-based technology companies venturing into the CVC landscape. Diverse giants, including global advertising agency WPP, oil major Chevron, and Korean conglomerate Samsung, underscored the expanding spectrum of technology investments.
Corporate Venturing in the Utilities Sector
Utilities: A Paradigm Shift
Historically, utilities have prioritized market share and pricing power over innovation. Corporate venturing in this sector has been cyclical, mirroring economic trends. However, telecom operators, such as Deutsche Telekom’s T-Venture, emerged as pioneers, navigating economic cycles to foster successful ventures.
Rising Wave of Utility Innovation
Utility companies are redefining their approach to innovation, with an increasing focus on external innovation and corporate venturing. The establishment of substantial corporate venturing funds, like Korea Telecom’s KRW1 trillion fund, signifies a growing commitment to driving innovation across the electric, gas, and phone industries.
Corporate Venturing in the Media Sector
Media Metamorphosis in the Digital Age
The media sector’s transformation is underscored by digitalization and evolving business models. Corporate venturing emerges as a vital tool to navigate this evolution, enabling media companies to grasp the nuances of change and adapt strategically.
Pioneering Success Stories
Success stories in the media sector shine a light on the transformative power of corporate venturing. Companies like South Africa-based Naspers and US-based Interactive Data Group have thrived in emerging markets, driving innovation and shaping media landscapes.
Shaping Transformative Ventures through CVC
Corporate venture capital transcends sectors, weaving a tapestry of strategic investments. Meticulous criteria guide decisions, fostering sustainable growth, innovation, and market influence. From healthcare to technology, utilities to media, CVC is the catalyst propelling industries into the future.
Exploring Corporate Ventures Across Diverse Sectors
In the ever-evolving world of business, corporate venturing emerges as a strategic beacon, illuminating pathways of innovation and growth. This transformative approach extends its reach across sectors, from energy and clean tech to finance, transport, and logistics. In this article, we delve into the multifaceted landscape of corporate venturing, uncovering its diverse realms and influential players.
Energizing Innovation in Clean-Tech
Clean Technology’s Transformative Potential
Clean technology, a realm where digital and wireless innovations intersect with energy and other industries, has sparked a paradigm shift. As consultants at Cleantech Group affirm, it stands as the “first global technological revolution.” The traction gained is palpable, with a notable +50% surge in corporate venturing into clean-tech and energy from 2005 to 2009, as tracked by Cleantech Group.
The Vanguard of Influence: Chevron
Within the energy and natural resource domain, US oil major Chevron stands as a beacon of influence. Garnering recognition from Global Corporate Venturing, Chevron takes the lead as the most influential corporate venturing unit, a testament to its strategic prowess in shaping energy landscapes.
Prominent Players in Clean-Tech Venturing
Expanding the horizons of clean-tech venturing, several industry giants wield their corporate venturing arms:
- Dow Venture Capital: With a diversified focus spanning materials science, alternative energy technologies, and water technologies, Dow Venture Capital contributes to the advancement of clean technology.
- Saint Gobain External Venturing: As the largest construction products manufacturer globally, Saint Gobain External Venturing facilitates strategic partnerships in green building, energy, and advanced materials spaces, fostering innovation.
- MAHLE Corporate Venture Capital: Guided by its corporate venture arm, MAHLE GmbH invests in cleantech- and automotive-related sectors, driving advancements in drive-train and mechatronics solutions.
- Energy Technology Ventures: A joint venture comprising General Electric, NRG Energy, and ConocoPhillips, Energy Technology Ventures is dedicated to ushering in next-generation energy technologies. Collaboration opportunities span renewable power generation, smart grid, energy efficiency, and more.
Revolutionizing Finance through Corporate Venturing
Unveiling Financial Services Engagement
The financial sector’s engagement with corporate venturing is longstanding, with banks and insurers as active limited partners in independent venture capital funds. The motivations underlying their investment activity are nuanced and multifaceted.
The Evolutionary Trajectory
The financial landscape has witnessed a shift in investor dynamics. While banks once sought early access to companies before their IPOs, changing market conditions and regulatory constraints reshaped the landscape. Despite the shifts, strategic investment by financial institutions, such as Hartford and Citigroup, highlights a new avenue of exploration, propelling product development and technology understanding.
Traversing Transport and Logistics Terrain
The transport and logistics sector embarks on a journey of resurgence, marked by technological infusion. Industry stalwarts like Volvo Group and General Motors have ventured into corporate venturing, fostering innovation through strategic investments.
Trailblazing Professional Organizations
Venturing beyond corporate realms, professional organizations assume pivotal roles in facilitating collaboration, knowledge exchange, and industry progress.
Notable entities include:
- Global Corporate Venturing: A media group driving news, data, and discussions within the entrepreneurial and venture community, fostering an environment of information exchange and growth.
- Strategic Venture Association: Dedicated to the corporate investing and strategic partnering community, this association cultivates collaboration and innovation, underscoring the importance of external partnerships in the current market landscape.
- National Venture Capital Association: Representing over 450 member firms, this association advocates for venture capital’s significance in the US economy, fostering entrepreneurial activity and innovation.
- ICEX Corporate Venturing Knowledge Exchange Community: A private exchange for CV executives at global corporations, ICEX facilitates strategic discussions, sharing insights and solutions to enhance business model innovation and investment activities.
Venturing Toward a Transformed Future
Corporate venturing weaves a tapestry that spans energy, finance, transport, and beyond. As influential players and visionary organizations contribute to innovation, growth, and transformation, the landscape of corporate venturing evolves, leaving an indelible mark on the business world.
Over 10 years Forex trading experience
High Performance Signals
Our trading plan aims to produce strong and consistent results with minimal drawdown. Whilst past performance is no guarantee of future results, we use a number of trading strategies that are specially tailored to different market conditions. Professional Forex traders are experts at managing risk and we make sure that each trade is very carefully controlled. We always use tight stop losses and closely monitor our positions to maximise our results but the choice to trade will always be yours.
